Even though the functional role of CSTF2 has not been conclusively proven, the overexpression results in the shortening of 3′ UTRs and promotes pathogenesis and poor prognosis in several types of cancer, including endometrial carcinoma, lung cancer, and bladder cancer (75–77). Here, CSTF2 is linked to endometrial carcinoma.